对于儿科脱发区域的全身疗法
Luiza Kalil1, DanTasia Welch2,3, Candrice R Heath2
1Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.
Pediatric dermatology
|March 5, 2025
概括
对儿科脱毛率 (AA) 的全身治疗方法进行了审查,发现有限的高质量证据. 雅努斯激酶抑制剂显示出有前途的效果,而口服的米诺西迪尔和杜皮卢马布也可能对某些患有这种自身免疫性脱发症的患者有好处.
科学领域:
- 皮肤病学 皮肤病学
- 儿科自身免疫性疾病 儿童自身免疫性疾病
- 脱发研究 脱发研究
背景情况:
- 脱发症 (alopecia areata) 是一种导致脱发的自身免疫性疾病,经常影响儿童.
- 轻微的病例可能会自发或通过局部治疗消失,但广泛的AA需要全身疗法.
- 儿科AA系统治疗的证据很少,主要来自病例报告和系列.
研究的目的:
- 审查现有的关于儿科大白发症全身治疗选择的文献.
- 评估AA儿童各种全身疗法的疗效和证据基础.
主要方法:
- 一个叙事的出版文献的叙事审查对儿科脱发症的全身治疗.
- 对病例报告,病例系列和有限的临床试验数据的分析.
主要成果:
- 简氏激酶 (JAK) 抑制剂是唯一一种药物类别,有系统数据支持其在儿科AA中使用.
- 口服米诺克西迪尔越来越多地报告了益处,特别是作为附加疗法.
- 杜皮卢马布可能有利于患有AA和同时存在的亚托皮的患者;全身皮质类固醇可以提供暂时的改善,但具有显著的风险和有限的持续疗效.
结论:
- 对于儿科脱发症的全身治疗,高质量的证据是有限的.
- 雅克抑制剂代表了一个有前途的治疗类,得到系统数据的支持.
- 口服米诺克西迪尔和杜比卢马布需要进一步研究,而传统免疫调节剂缺乏大量支持性文献.
相关概念视频
Skin Cancer
3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K
Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Skin Diseases and Disorders
2.8K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
2.8K
Inflammatory Bowel Disease IV: Pharmacological Management
88
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
88


